Open- | Close- |
Vol / Avg.3.898K / 1.213M | Mkt Cap4.895M |
Day Range- - - | 52 Wk Range2.900 - 18.848 |
Bluejay Diagnostics Stock (NASDAQ: BJDX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.3.898K / 1.213M | Mkt Cap4.895M |
Day Range- - - | 52 Wk Range2.900 - 18.848 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.500 | -2.750 | -1.2500 | ||||
REV | 420.000K | 0 | -420.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-03 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-01-12 | Dawson James | Jason Kolbert | Initiates Coverage On | Buy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap | ||
---|---|---|---|---|---|
BJDX | Bluejay Diagnostics | -4.59% | 4.9M | ||
VTAK | |||||
NDRA | ENDRA Life Sciences | -2.7% | 8.1M | ||
NXL | Nexalin Technology | 0% | 3.1M | ||
TLIS | Talis Biomedical | -1.46% | 10.5M |
You can purchase shares of Bluejay Diagnostics (NASDAQ: BJDX) through any online brokerage.
Other companies in Bluejay Diagnostics’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Nexalin Technology (NASDAQ:NXL), Talis Biomedical (NASDAQ:TLIS) and Motus GI Hldgs (NASDAQ:MOTS).
The latest price target for Bluejay Diagnostics (NASDAQ: BJDX) was reported by Dawson James on Thursday, August 3, 2023. The analyst firm set a price target for 0.00 expecting BJDX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Bluejay Diagnostics (NASDAQ: BJDX) is $3.95 last updated Today at October 3, 2023 at 12:56 PM UTC.
There is no dividend information for Bluejay Diagnostics.
Bluejay Diagnostics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Bluejay Diagnostics.
Bluejay Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Bluejay Diagnostics Stock (NASDAQ: BJDX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.3.898K / 1.213M | Mkt Cap4.895M |
Day Range- - - | 52 Wk Range2.900 - 18.848 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.500 | -2.750 | -1.2500 | ||||
REV | 420.000K | 0 | -420.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-03 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-01-12 | Dawson James | Jason Kolbert | Initiates Coverage On | Buy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap | ||
---|---|---|---|---|---|
BJDX | Bluejay Diagnostics | -4.59% | 4.9M | ||
VTAK | |||||
NDRA | ENDRA Life Sciences | -2.7% | 8.1M | ||
NXL | Nexalin Technology | 0% | 3.1M | ||
TLIS | Talis Biomedical | -1.46% | 10.5M |
You can purchase shares of Bluejay Diagnostics (NASDAQ: BJDX) through any online brokerage.
Other companies in Bluejay Diagnostics’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Nexalin Technology (NASDAQ:NXL), Talis Biomedical (NASDAQ:TLIS) and Motus GI Hldgs (NASDAQ:MOTS).
The latest price target for Bluejay Diagnostics (NASDAQ: BJDX) was reported by Dawson James on Thursday, August 3, 2023. The analyst firm set a price target for 0.00 expecting BJDX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Bluejay Diagnostics (NASDAQ: BJDX) is $3.95 last updated Today at October 3, 2023 at 12:56 PM UTC.
There is no dividend information for Bluejay Diagnostics.
Bluejay Diagnostics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Bluejay Diagnostics.
Bluejay Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Bluejay Diagnostics Stock (NASDAQ: BJDX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.3.898K / 1.213M | Mkt Cap4.895M |
Day Range- - - | 52 Wk Range2.900 - 18.848 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.500 | -2.750 | -1.2500 | ||||
REV | 420.000K | 0 | -420.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-03 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-01-12 | Dawson James | Jason Kolbert | Initiates Coverage On | Buy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap | ||
---|---|---|---|---|---|
BJDX | Bluejay Diagnostics | -4.59% | 4.9M | ||
VTAK | |||||
NDRA | ENDRA Life Sciences | -2.7% | 8.1M | ||
NXL | Nexalin Technology | 0% | 3.1M | ||
TLIS | Talis Biomedical | -1.46% | 10.5M |
You can purchase shares of Bluejay Diagnostics (NASDAQ: BJDX) through any online brokerage.
Other companies in Bluejay Diagnostics’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Nexalin Technology (NASDAQ:NXL), Talis Biomedical (NASDAQ:TLIS) and Motus GI Hldgs (NASDAQ:MOTS).
The latest price target for Bluejay Diagnostics (NASDAQ: BJDX) was reported by Dawson James on Thursday, August 3, 2023. The analyst firm set a price target for 0.00 expecting BJDX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Bluejay Diagnostics (NASDAQ: BJDX) is $3.95 last updated Today at October 3, 2023 at 12:56 PM UTC.
There is no dividend information for Bluejay Diagnostics.
Bluejay Diagnostics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Bluejay Diagnostics.
Bluejay Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Bluejay Diagnostics Stock (NASDAQ: BJDX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.3.898K / 1.213M | Mkt Cap4.895M |
Day Range- - - | 52 Wk Range2.900 - 18.848 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.500 | -2.750 | -1.2500 | ||||
REV | 420.000K | 0 | -420.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-03 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-01-12 | Dawson James | Jason Kolbert | Initiates Coverage On | Buy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap | ||
---|---|---|---|---|---|
BJDX | Bluejay Diagnostics | -4.59% | 4.9M | ||
VTAK | |||||
NDRA | ENDRA Life Sciences | -2.7% | 8.1M | ||
NXL | Nexalin Technology | 0% | 3.1M | ||
TLIS | Talis Biomedical | -1.46% | 10.5M |
You can purchase shares of Bluejay Diagnostics (NASDAQ: BJDX) through any online brokerage.
Other companies in Bluejay Diagnostics’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Nexalin Technology (NASDAQ:NXL), Talis Biomedical (NASDAQ:TLIS) and Motus GI Hldgs (NASDAQ:MOTS).
The latest price target for Bluejay Diagnostics (NASDAQ: BJDX) was reported by Dawson James on Thursday, August 3, 2023. The analyst firm set a price target for 0.00 expecting BJDX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Bluejay Diagnostics (NASDAQ: BJDX) is $3.95 last updated Today at October 3, 2023 at 12:56 PM UTC.
There is no dividend information for Bluejay Diagnostics.
Bluejay Diagnostics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Bluejay Diagnostics.
Bluejay Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Bluejay Diagnostics Stock (NASDAQ: BJDX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.3.898K / 1.213M | Mkt Cap4.895M |
Day Range- - - | 52 Wk Range2.900 - 18.848 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.500 | -2.750 | -1.2500 | ||||
REV | 420.000K | 0 | -420.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-03 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-01-12 | Dawson James | Jason Kolbert | Initiates Coverage On | Buy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap | ||
---|---|---|---|---|---|
BJDX | Bluejay Diagnostics | -4.59% | 4.9M | ||
VTAK | |||||
NDRA | ENDRA Life Sciences | -2.7% | 8.1M | ||
NXL | Nexalin Technology | 0% | 3.1M | ||
TLIS | Talis Biomedical | -1.46% | 10.5M |
You can purchase shares of Bluejay Diagnostics (NASDAQ: BJDX) through any online brokerage.
Other companies in Bluejay Diagnostics’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Nexalin Technology (NASDAQ:NXL), Talis Biomedical (NASDAQ:TLIS) and Motus GI Hldgs (NASDAQ:MOTS).
The latest price target for Bluejay Diagnostics (NASDAQ: BJDX) was reported by Dawson James on Thursday, August 3, 2023. The analyst firm set a price target for 0.00 expecting BJDX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Bluejay Diagnostics (NASDAQ: BJDX) is $3.95 last updated Today at October 3, 2023 at 12:56 PM UTC.
There is no dividend information for Bluejay Diagnostics.
Bluejay Diagnostics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Bluejay Diagnostics.
Bluejay Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Bluejay Diagnostics Stock (NASDAQ: BJDX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.3.898K / 1.213M | Mkt Cap4.895M |
Day Range- - - | 52 Wk Range2.900 - 18.848 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.500 | -2.750 | -1.2500 | ||||
REV | 420.000K | 0 | -420.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-03 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-01-12 | Dawson James | Jason Kolbert | Initiates Coverage On | Buy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap | ||
---|---|---|---|---|---|
BJDX | Bluejay Diagnostics | -4.59% | 4.9M | ||
VTAK | |||||
NDRA | ENDRA Life Sciences | -2.7% | 8.1M | ||
NXL | Nexalin Technology | 0% | 3.1M | ||
TLIS | Talis Biomedical | -1.46% | 10.5M |
You can purchase shares of Bluejay Diagnostics (NASDAQ: BJDX) through any online brokerage.
Other companies in Bluejay Diagnostics’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Nexalin Technology (NASDAQ:NXL), Talis Biomedical (NASDAQ:TLIS) and Motus GI Hldgs (NASDAQ:MOTS).
The latest price target for Bluejay Diagnostics (NASDAQ: BJDX) was reported by Dawson James on Thursday, August 3, 2023. The analyst firm set a price target for 0.00 expecting BJDX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Bluejay Diagnostics (NASDAQ: BJDX) is $3.95 last updated Today at October 3, 2023 at 12:56 PM UTC.
There is no dividend information for Bluejay Diagnostics.
Bluejay Diagnostics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Bluejay Diagnostics.
Bluejay Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Bluejay Diagnostics Stock (NASDAQ: BJDX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.3.898K / 1.213M | Mkt Cap4.895M |
Day Range- - - | 52 Wk Range2.900 - 18.848 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.500 | -2.750 | -1.2500 | ||||
REV | 420.000K | 0 | -420.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-03 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-01-12 | Dawson James | Jason Kolbert | Initiates Coverage On | Buy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap | ||
---|---|---|---|---|---|
BJDX | Bluejay Diagnostics | -4.59% | 4.9M | ||
VTAK | |||||
NDRA | ENDRA Life Sciences | -2.7% | 8.1M | ||
NXL | Nexalin Technology | 0% | 3.1M | ||
TLIS | Talis Biomedical | -1.46% | 10.5M |
You can purchase shares of Bluejay Diagnostics (NASDAQ: BJDX) through any online brokerage.
Other companies in Bluejay Diagnostics’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Nexalin Technology (NASDAQ:NXL), Talis Biomedical (NASDAQ:TLIS) and Motus GI Hldgs (NASDAQ:MOTS).
The latest price target for Bluejay Diagnostics (NASDAQ: BJDX) was reported by Dawson James on Thursday, August 3, 2023. The analyst firm set a price target for 0.00 expecting BJDX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Bluejay Diagnostics (NASDAQ: BJDX) is $3.95 last updated Today at October 3, 2023 at 12:56 PM UTC.
There is no dividend information for Bluejay Diagnostics.
Bluejay Diagnostics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Bluejay Diagnostics.
Bluejay Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Bluejay Diagnostics Stock (NASDAQ: BJDX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.3.898K / 1.213M | Mkt Cap4.895M |
Day Range- - - | 52 Wk Range2.900 - 18.848 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.500 | -2.750 | -1.2500 | ||||
REV | 420.000K | 0 | -420.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-03 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-01-12 | Dawson James | Jason Kolbert | Initiates Coverage On | Buy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap | ||
---|---|---|---|---|---|
BJDX | Bluejay Diagnostics | -4.59% | 4.9M | ||
VTAK | |||||
NDRA | ENDRA Life Sciences | -2.7% | 8.1M | ||
NXL | Nexalin Technology | 0% | 3.1M | ||
TLIS | Talis Biomedical | -1.46% | 10.5M |
You can purchase shares of Bluejay Diagnostics (NASDAQ: BJDX) through any online brokerage.
Other companies in Bluejay Diagnostics’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Nexalin Technology (NASDAQ:NXL), Talis Biomedical (NASDAQ:TLIS) and Motus GI Hldgs (NASDAQ:MOTS).
The latest price target for Bluejay Diagnostics (NASDAQ: BJDX) was reported by Dawson James on Thursday, August 3, 2023. The analyst firm set a price target for 0.00 expecting BJDX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Bluejay Diagnostics (NASDAQ: BJDX) is $3.95 last updated Today at October 3, 2023 at 12:56 PM UTC.
There is no dividend information for Bluejay Diagnostics.
Bluejay Diagnostics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Bluejay Diagnostics.
Bluejay Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Bluejay Diagnostics Stock (NASDAQ: BJDX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.3.898K / 1.213M | Mkt Cap4.895M |
Day Range- - - | 52 Wk Range2.900 - 18.848 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.500 | -2.750 | -1.2500 | ||||
REV | 420.000K | 0 | -420.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-03 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
2022-01-12 | Dawson James | Jason Kolbert | Initiates Coverage On | Buy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap | ||
---|---|---|---|---|---|
BJDX | Bluejay Diagnostics | -4.59% | 4.9M | ||
VTAK | |||||
NDRA | ENDRA Life Sciences | -2.7% | 8.1M | ||
NXL | Nexalin Technology | 0% | 3.1M | ||
TLIS | Talis Biomedical | -1.46% | 10.5M |
You can purchase shares of Bluejay Diagnostics (NASDAQ: BJDX) through any online brokerage.
Other companies in Bluejay Diagnostics’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Nexalin Technology (NASDAQ:NXL), Talis Biomedical (NASDAQ:TLIS) and Motus GI Hldgs (NASDAQ:MOTS).
The latest price target for Bluejay Diagnostics (NASDAQ: BJDX) was reported by Dawson James on Thursday, August 3, 2023. The analyst firm set a price target for 0.00 expecting BJDX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Bluejay Diagnostics (NASDAQ: BJDX) is $3.95 last updated Today at October 3, 2023 at 12:56 PM UTC.
There is no dividend information for Bluejay Diagnostics.
Bluejay Diagnostics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Bluejay Diagnostics.
Bluejay Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.